By Denny Jacob

Haleon voluntarily recalled two versions of cough medicine Robitussin due to a microbial contamination.

The personal healthcare products provider said the recall affects eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult at the consumer level.

Haleon said the use of the affected product in immunocompromised individuals could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection. In non-immunocompromised consumers, the population most likely to use the product, life-threatening infections aren't likely to occur, it added.

Haleon said to date it hasn't received reports of adverse events related to the recall.

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

January 24, 2024 10:43 ET (15:43 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.
Grafico Azioni Haleon (LSE:HLN)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Haleon
Grafico Azioni Haleon (LSE:HLN)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Haleon